SCHEMBL27689266

SCHEMBL27689266

Nc1ccn(OP(=O)(O)OCO)c(=O)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 3/20 0.47
▸ SLC22A6 Q4U2R8 1/20 0.46
▸ POLG P54098 2/20 0.38
▸ POLB P06746 1/20 0.36
▸ LMNA P02545 3/20 0.36
▸ THRB P10828 1/20 0.36
▸ MTOR P42345 1/20 0.36
▸ MDM2 Q00987 1/20 0.36
▸ NCOA1 Q15788 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ P2RY2 P41231 1/20 0.36
▸ PDE3A Q14432 3/20 0.34
▸ CACNA1F O60840 2/20 0.34
▸ ALB P02768 2/20 0.34
▸ MAPT P10636 2/20 0.34
▸ CACNA1D Q01668 2/20 0.34
▸ CACNA1S Q13698 2/20 0.34
▸ CACNA1C Q13936 2/20 0.34
▸ POLA1 P09884 1/20 0.34
▸ PDE4D Q08499 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1144357 0.82 POLG (0.44) FGFR1SLC22A6POLGPOLBLMNA
SCHEMBL1629582 0.82 FGFR1 (0.44) FGFR1SLC22A6POLGPOLBLMNA
SCHEMBL76047 0.80 POLG (0.47) FGFR1SLC22A6POLGPOLBP2RY2
SCHEMBL10496372 0.80 POLG (0.47) FGFR1SLC22A6POLGPOLBP2RY2
SCHEMBL26123976 0.79 POLG (0.47) FGFR1SLC22A6POLGPOLBP2RY2
SCHEMBL28004770 0.77 FGFR1 (0.40) FGFR1SLC22A6POLGPOLBLMNA
SCHEMBL28199180 0.77 FGFR1 (0.37) FGFR1SLC22A6POLGPOLBP2RY2
SCHEMBL5356639 0.77 FGFR1 (0.39) FGFR1SLC22A6POLGPOLBLMNA
SCHEMBL24512713 0.76 FGFR1 (0.36) FGFR1SLC22A6POLGPOLBP2RY2
SCHEMBL27480335 0.74 LMNA (0.53) POLBLMNATHRBMTORMDM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101132795-A Compounds useful in the treatment of HIV MEDIVIR AB (SE) 2008-02-27 — — CN disclosed
Send feedback